Related Experiment Video
Updated: Apr 5, 2026
06:20
Author Spotlight: Advancing VRL Diagnosis Using Cell-Free DNA Extraction from Vitreous Humor
Published on: January 12, 2024
2.8K
Ocular Adnexal Lymphomas: Single-Center Experience
Melda Cömert Özkan1, Melis Palamar2, Murat Tombuloğlu1
1Department of Hematology, School of Medicine, Ege University, İzmir, Turkey.
Clinical Lymphoma, Myeloma & Leukemia
|August 23, 2015
Summary
Ocular adnexal lymphoma (OAL) is a rare eye-area cancer increasing annually. Due to high recurrence, tailored treatments are essential for managing this orbital malignancy.
Area of Science:
- Ophthalmology
- Oncology
- Hematology
Background:
- Ocular adnexal lymphoma (OAL) is a rare non-Hodgkin lymphoma affecting eye-related tissues.
- OAL constitutes a small percentage of lymphomas but is the leading orbital malignancy.
- The incidence of OAL has shown a significant annual increase over the past two decades.
Purpose of the Study:
- To review the current understanding of Ocular Adnexal Lymphoma (OAL).
- To highlight the increasing incidence and challenges in OAL management.
- To emphasize the need for standardized treatment protocols for OAL.
Main Methods:
- Literature review of Ocular Adnexal Lymphoma (OAL) studies.
- Analysis of epidemiological trends in orbital malignancies.
- Synthesis of current treatment approaches and recurrence data for OAL.
Main Results:
- OAL incidence is rising approximately 6% annually.
- OAL is the predominant malignancy of the orbit.
- High rates of local and extraorbital recurrence are observed in OAL patients.
Conclusions:
- Ocular adnexal lymphoma (OAL) requires careful management due to its increasing prevalence and recurrence rates.
- The lack of uniform treatment guidelines necessitates further research and consensus.
- Effective local, systemic, or combined therapies are crucial for improving outcomes in OAL.
Related Concept Videos
01:15Secondary Lymphoid Organs
10.3K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
10.3K
01:16Primary Lymphoid Organs
16.8K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
16.8K
01:27Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K